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SUMMARY – A 70-year-old patient was admitted to the Department of Oral Medicine for 
multiple oral ulcerations on the left buccal mucosa, around 0.5 cm in diameter, as well as on the 
 gingiva. Otherwise, the patient suff ered from chronic lymphocytic leukemia, hypogammaglobu-
linemia, chronic renal insuffi  ciency, with complete afunction of the right kidney, asthma, hypertension, 
gastritis and prostate hyperplasia. Diff erential diagnosis of oral ulcerations included drug induced oral 
ulcerations, paraneoplastic pemphigus, viral ulcerations (cytomegalovirus, herpes simplex viruses), 
fungal ulcerations (candidiasis, aspergillosis, histoplasmosis, cryptococcosis) and bacterial ulcerations, 
as well as neutropenic ulcers. One of the possible explanations was that the lesions were due to the use 
of drugs, the more so as oral lesions evolved when the doses of allopurinol and chlorambucil were 
increased, and subsided when the doses of both drugs were decreased. However, we could not establish 
for sure whether the lesions were due to allopurinol or chlorambucil. According to literature data, 
 allopurinol is one of the most frequent drugs known to induce skin adverse reactions, therefore we 
assumed that it was the culprit drug. Unfortunately, several weeks later the patient died from sepsis, 
pneumonia with respiratory insuffi  ciency and multiorgan failure.
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Introduction
Sometimes it is very diffi  cult to fi nd out what is the 
exact cause of oral ulcers, especially in patients that are 
immunosuppressed and take many drugs. Oral ulcers 
can be induced by the following causes: 1) traumatic; 
2) microbial (viral, bacterial and fungal); 3) autoim-
mune mediated such as recurrent aphthous ulcers; 4) 
related to systemic diseases such as gastrointestinal 
(gluten enteropathy and Crohn’s disease) and hemato-
poietic ones such as iron defi ciency and neutropenia; 
5) vesiculobullous diseases such as pemphigus, pem-
phigoid; 6) malignant oral diseases such as oral squa-
mous cell carcinoma, diff use large B cell lymphoma 
and metastases; 7) self-infl icted lesions in psychiatric 
patients such as bulimia; 8) adverse drug reactions; and 
9) neutropenic ulcerations1.
Oral ulcers are well known side eff ects of drug 
therapy; however, their exact etiopathogenesis is poor-
ly understood. It is important to defi ne when the ul-
cerations began, or if they worsened de novo upon in-
creased drug dosage2, as in our case.
It is well known that nonsteroidal anti-infl amma-
tory drugs (NSAIDs) and beta blockers (labetalol, 
captopril, nicorandil) may lead to the development of 
oral ulceration. Nicorandil induced oral ulcerations are 
probably caused by its metabolites. It is known that 
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there are large individual variations in the activity of 
enzyme nicotinamide N-methyltranferase that cata-
lyzes methyl conjugation of nicotinamide, an interme-
diate formed by denitration of nicorandil. NSAIDs 
may cause mucosal ulceration due to local vasocon-
striction. Mouth ulcers can occur as side eff ects of im-
munosuppressive therapy which may lead to activation 
of herpes virus or other viruses such as cytomegalovi-
rus (CMV). Phenylbutazone can cause agranulocyto-
sis which may manifest with oral ulcerations. Th e only 
proper diagnosis of the drug-induced oral ulceration is 
re-challenge, which is unethical unless the drug is un-
replaceable. Re-challenge poses the risk of anaphylac-
tic reaction3.
Oral adverse reactions to drugs depend on the dose 
and type of medication, as well as on individual diff er-
ences related to the patient. Oral adverse reactions to 
drugs may be rapid but can also develop a few years 
after the drug has been initiated. In most drug-induced 
oral reactions, improvement of clinical symptoms oc-
curs after dose reduction or upon discontinuation of 
the off ending drug4,5. Hernandez et al.6 have described 
a case of a patient in whom resolution of oral ulcer-
ation occurred after decreasing the dosage of tacroli-
mus. It seems that this phenomenon may be related to 
the drug half-life. Of course, severe reactions require 
rapid withdrawal of the off ending drug.
So far, some drugs have been implicated in the eti-
ology of oral ulcers such as sodium lauryl sulfate, ser-
traline hydrochloride, NSAIDs, ferrous sulfate, la-
motrigine, tacrolimus, mycophenolate mofetil, siroli-
mus, nicorandil, captopril, labetalol, calcium channel 
blockers, foscarnet, alendronate, protease inhibitors, 
interferon and 2’3’-dideoxycytidine, aspirin, pancreatic 
supplements, metamizole, tiotropium bromide and 
sulfonamides7.
Case Report
A 70-year-old male patient was referred to our De-
partment. Clinically, the lesions appeared as three oral 
ulcerations on his left buccal mucosa approximately 
0.5 cm in diameter and the same type of lesions could 
be seen on the upper and lower gingiva (Figs. 1 and 2). 
Th e whole oral mucosa was thinned and pale.
Detailed medical history revealed that he suff ered 
from chronic lymphocytic leukemia, hypogammaglob-
ulinemia, chronic renal insuffi  ciency, with complete 
afunction of the right kidney, asthma, degenerative 
laryngopathy, hypertension, gastritis and prostate hy-
perplasia.
Upon admission to our Department, he was taking 
methylprednisolone (Medrol), aciclovir (Herplex), 
pantoprazole (Controloc), allopurinol (Alopurinol), 
lercanidipine (Lercanil), losartan (Losartic), cicle-
sonide (Alvesco), albuterol sulfate (Ventolin), lorata-
dine (Rinolan), tamsulosine (Omnic), diazepam 
(Normabel), budesonidum (Tafen) and montelukast 
(Melarth).
Complete blood count revealed the following fi nd-
ings: L 4.0 (x109) (normal range 3.4-9.7); erythrocytes 
3.71 (x1012) (4.34-5.72); hemoglobin 108 g/L (138-
175); hematocrit 0.33 (L/L) (0.415-0.530); MCV 
Fig. 1. Lesions on the left buccal mucosa on admission.
Fig. 2. Lesions on the mandibular labial and gingival 
mucosa.
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88.9 (fL) (83-97.2); platelets 87 (x109/L) (158-424); 
C-reactive protein 43.7 (<5); neutrophil range 66%.
Histopathologic fi nding showed granulation tissue 
with rare to medium abundant mononuclear infl am-
matory infi ltration; however, no macrophages with in-
clusions were seen. Direct and indirect immunofl uo-
rescence (DIF and IIF) fi nding showed no immuno-
globulin and complement deposits.
At presentation, we thought the patient had CMV 
induced oral lesions and he was referred for viral blood 
tests (real time PCR, Qiagen CMV LC PCR Kit), 
which revealed CMV viremia. He was immediately 
administered valaganciclovir therapy together with 
acyclovir, fl uconazole and azithromycin, with local im-
provement. Our working diagnosis was drug (allopuri-
nol or chlorambucil) induced oral ulceration, as the 
lesions started when allopurinol dose was increased 
from 100 mg to 300 mg and subsided when allopuri-
nol dose was 200 mg. At the same time, chlorambucil 
was reduced from the dose of 16 mg to 2 mg because 
leukocyte number was normalized. Th e lesions began 
to heal (Fig. 3). Unfortunately, several weeks later, the 
patient died from sepsis, pneumonia with respiratory 
insuffi  ciency and multiorgan failure.
Discussion
Notwithstanding the clinical importance of treat-
ment-related toxicities, dermatologic and mucosal dis-
turbances may also precede, coincide or follow the di-
agnosis of cancer. Th is case was quite peculiar due to 
the simultaneous occurrence of oral ulceration and 
certain systemic conditions which may have led to the 
development of oral ulceration in this patient. Th e his-
topathologic fi nding was not suggestive of viral infec-
tion (neither herpes nor CMV) or fungal infection. 
Moreover, immunohistochemistry of oral lesions did 
not reveal the presence of either CMV or herpes sim-
plex virus (HSV). DIF and IIF were also negative, 
therefore the diagnosis of pemphigus, paraneoplastic 
pemphigus and pemphigoid was discarded. We 
thought that maybe this was fungal infection (candidal 
or cryptococcal), as the lesions cleared when fl ucon-
azole was introduced, however, no fungi were found in 
the histopathology specimen.
At the end, our working diagnosis was drug (allo-
purinol or chlorambucil) induced oral ulceration, as 
the lesions started when allopurinol dose was increased 
from 100 mg to 300 mg and the lesions subsided when 
allopurinol dose was reduced to 200 mg as kidney 
function improved. At the same time, chlorambucil 
was reduced from the dose of 16 mg to 2 mg because 
leukocyte count was normalized. It is well known that 
allopurinol dose increase leads to the more frequent 
occurrence of Stevens-Johnson syndrome (SJS) and 
toxic epidermal necrolysis (TEN). Furthermore, the 
use of 200 mg or more of allopurinol daily was associ-
ated with a higher risk of SJS or TEN compared with 
lower daily doses, as reported by Halevy et al.8.
Th ere have been few case reports on skin granulo-
ma annulare in patients as a side eff ect of allopurinol; 
however, to our knowledge, there are not many case 
reports on Pubmed on oral manifestations of allopuri-
nol therapy. Abdollahi and Radfar9 have reported that 
allopurinol might induce erythema multiforme, oral 
ulceration and oral lichenoid changes. Marra and 
Wunderle10 report the fi rst case of toxic epidermal 
necrolysis associated with allopurinol therapy, which 
initially presented with oral ulceration. Chau et al.11 
describe oral lichenoid reactions due to allopurinol 
therapy in four patients.
We cannot describe the underlying mechanism by 
which allopurinol might lead to development of oral 
ulcers. It is possible that the mechanisms include im-
mune complex deposition, an immune response di-
rected against the metabolites of allopurinol or allopu-
rinol hypersensitivity exclusively localized to oral mu-
cosa, as it has been described for allopurinol induced 
skin lesions such as granulomatous dermatitis12,13.
Fig. 3. Healed lesions on buccal mucosa.
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Regarding chlorambucil, there have also been few 
case reports on oral and skin induced lesions. Pietran-
tonio et al.14 have reported a case of a patient who de-
veloped confl uent maculopapular erythema and large 
fl accid bullae on the trunk, legs and mucous mem-
branes, with fever up to 38 °C. TEN was confi rmed by 
skin patch test followed by skin biopsy.
Levin and Libster have reported two cases of high 
fever and progressive lymphadenopathy in patients 
treated with chlorambucil. Th e authors conclude that 
allergic reactions to chlorambucil are rare, however, 
previously urticaria, angioedema, rashes, TEN, drug 
fever and one case of immune hemolytic anemia have 
been described15.
Th e case presented shows that oral fi nding looking 
like a CMV infection probably was a drug-induced 
oral lesion (due to either allopurinol or chlorambucil).
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Sažetak
LIJEKOVIMA IZAZVANE ORALNE ULCERACIJE: PRIKAZ SLUČAJA
V. Vučičević Boras, S. Židovec-Lepej, B. Marinović, S. Seiwerth, I. Škrinjar, D. Pulanić  i D. Vidović Juras
Bolesnik u dobi od 70 godina upućen je na Zavod za oralnu medicinu zbog nekoliko oralnih ulceracija na lijevoj obraznoj 
sluznici veličine oko pola centimetra u promjeru te na gingivi. Inače je bolovao od kronične limfocitne leukemije, hipogama-
globulinemije, kronične bubrežne insufi cijencije s potpunom afunkcijom desnog bubrega, astme, hipertenzije, gastritisa i 
hiperplazije prostate. Diferencijalna dijagnoza oralnih ulceracija uključivala je oralne ulceracije uslijed uzimanja lijekova, 
paraneoplastični pemfi gus, virusne ulceracije (citomegalovirus, herpes simpleks viruse), gljivične ulceracije (kandidijaza, 
 aspergiloza, histoplazmoza, kriptokokoza), bakterijske ulceracije te neutropenične ulceracije. Jedno od mogućih objašnjenja 
je bilo da su lezije vjerojatno nastale uslijed uzimanja lijekova, jer su se pojavile kada se doza alopurinola i klorambucila 
 povećala, a počele su nestajati kada se doza tih lijekova smanjila. Ipak, nismo sigurni koji je od ova dva lijeka doveo do 
 nastanka lezija, jer je nažalost nekoliko tjedana poslije bolesnik izdahnuo uslijed sepse, pneumonije i respiracijske insufi cijen-
cije te višeorganskog zatajenja.
Ključne riječi: Oralni ulkus; Uzimanje lijekova, popratni učinci i štetna djelovanja; Prikazi slučaja
